Glenmark set to launch FabiFlu 400mg for Covid-19 treatment in India
New Delhi: Glenmark Pharmaceuticals, a research-led global pharmaceutical company, Thursday announced that it is set to introduce a 400 mg ...
Read moreDetailsNew Delhi: Glenmark Pharmaceuticals, a research-led global pharmaceutical company, Thursday announced that it is set to introduce a 400 mg ...
Read moreDetailsNew Delhi: Glenmark Pharmaceuticals said Wedensday that the Phase 3 clinical trial of antiviral drug Favipiravir is giving hope. Glenmark ...
Read moreDetailsNew Delhi: Shares of Glenmark Pharmaceuticals on Monday tumbled nearly 6 per cent after India's drug regulator sought clarification from ...
Read moreDetailsNew Delhi: Drug firm Glenmark Pharmaceuticals said Monday it has cut price of antiviral drug ‘Favipiravir’. The drug is sold under ...
Read moreDetails
By Aakar Patel My thesis is that the Indian state under Hindutva is incompletely communal. I have written about this...
Read moreDetailsBy Dilip Cherian The litany of extensions continues. The latest is Defence Secretary Rajesh Kumar Singh, whose tenure the Modi...
Read moreDetailsThe angry young generation is rising in protest in India, France, Spain, Italy, Germany, Poland and Serbia, to name a...
Read moreDetailsBrazil has come as a surprise at a time when extreme Right parties in Europe, Latin America and elsewhere, helped...
Read moreDetails

